Belgium· BE-AMP-SAM158042-00
Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml
A glycopyrronium bromid product containing neostigmine metilsulfate, registered in Belgium by Eumedica Pharmaceuticals. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC A03AB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Neostigmine Metilsulfate
- Manufacturer
- Eumedica Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- A03AB02
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1113323
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromid in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNeostigminemethylsulfaat CF 0,5 mg/ml, injectievloeistofCentrafarm B.V.
- CzechiaSYNTOSTIGMINBB Pharma a.s., Praha
- NorwayNeostig-carinopharmCarinopharm
- PolandPolstigminumTeva Pharmaceuticals Polska Sp. z o.o.
- United StatesBloxiverzExela Pharma Sciences, LLC
- GermanyNeostigCarinopharm Gmbh
- CanadaNEOSTIGMINE METHYLSULFATE INJECTION USPMARCAN PHARMACEUTICALS INC
- FranceNEOSTIGMINE RENAUDIN 5 mg/5 mL, solution injectableLABORATOIRE RENAUDIN
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Neostig, Normastigmin
- Cyprus · Neostigmine Cooper
- Czechia · Syntostigmin
- Germany · Neostig, Neostigmin Panpharma
- Spain · Neostigmina Braun
- France · Néostigmine Renaudin, Prostigmine
- United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
- Greece · Neostigmine Cooper
- Croatia · Neostigmin Panpharma
- Hungary · Neostigmine Kalceks, Stigmosan
- Latvia · Neostigmine Kalceks
- Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
- Poland · Polstigminum
- Portugal · Neostigmina Braun
- Romania · Miostin
- Sweden · Neostigmin Unimedic Pharma Ab
- Slovakia · Syntostigmin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4fc3439a-7f77-473f-804f-82f3c5b56f9f GET /v1/drugs/4fc3439a-7f77-473f-804f-82f3c5b56f9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
"name_fr": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
"name_nl": "Robinul-Neostigmine 0.5 mg/ml - 2.5 mg/ml",
"amp_code": "SAM158042-00",
"strengths": [
"2.5000",
"0.5000",
"23.1000"
],
"pack_count": 1,
"substances": [
"Neostigmine Metilsulfate",
"Glycopyrronium Bromide",
"Sodium Hydroxide",
"Sodium Phosphate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Glycopyrronium Bromide",
"authorisation_numbers": [
"BE158042"
]
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.